
Proposed Injective ETF plans to stake 90% of INJ tokens, pending regulatory approval.
Canary Capital has proposed an exchange-traded fund (ETF) that would stake at least 90% of its Injective (INJ) token holdings under normal conditions. The fund aims to hold INJ directly and delegate tokens to validators on the Injective network to ea...





